Chalcone

Chalcone

SCHEMBL29922932

O=C(/C=C/c1ccccc1)c1ccccc1.OO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 10/20 1.00
MAPT P10636 6/20 1.00
MAOB P27338 6/20 1.00
LMNA P02545 2/20 1.00
BCHE P06276 2/20 1.00
TNFRSF1A P19438 2/20 1.00
PLIN1 O60240 1/20 1.00
ACHE P22303 1/20 1.00
RECQL P46063 1/20 1.00
PLIN5 Q00G26 1/20 1.00
ABHD5 Q8WTS1 1/20 1.00
CYP3A4 P08684 5/20 0.78
KMT2A Q03164 4/20 0.78
HSPD1 P10809 3/20 0.78
HSPE1 P61604 3/20 0.78
NFKB1 P19838 2/20 0.78
RAB9A P51151 2/20 0.78
NFKB2 Q00653 2/20 0.78
RELA Q04206 2/20 0.78
MEN1 O00255 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chalcone SCHEMBL454583 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL27580 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL28306720 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL27581 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL29396001 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL2404758 1.00 CYP1B1 (1.00) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL2427445 0.98 CYP1B1 (0.96) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL527181 0.98 CYP1B1 (0.96) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL7861207 0.98 CYP1B1 (0.96) CYP1B1MAPTMAOBLMNABCHE
Chalcone SCHEMBL7653806 0.98 CYP1B1 (0.96) CYP1B1MAPTMAOBLMNABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591305-B2 Method for producing fisetin or fisetin derivatives DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2023-02-28 US disclosed
US-20220220088-A1 METHOD FOR PRODUCING FISETIN OR FISETIN DERIVATIVES DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220220088-A1 METHOD FOR PRODUCING FISETIN OR FISETIN DERIVATIVES FIS1, DNM2, SIRT5 CYP1B1 1101/4885MAPT 3098/4885MAOB 924/4885
US-11591305-B2 Method for producing fisetin or fisetin derivatives FIS1, DNM2, SIRT5 CYP1B1 1101/4885MAPT 3098/4885MAOB 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.